parecoxib has been researched along with Sepsis in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Chen, Q; Guo, Y; Min, S; Wu, B | 1 |
Clement, HW; Jargon, D; Schulz, K; Sommer, O; Strate, T; Utzolino, S; von Dobschuetz, E | 1 |
Bosselmann, S; Chada, M; Gessner, A; Kandler, M; Nögel, SC; Rascher, W; Schmidt, AM; Schneider, H; Schweer, H; Watzer, B | 1 |
3 other study(ies) available for parecoxib and Sepsis
Article | Year |
---|---|
Parecoxib ameliorates renal toxicity and injury in sepsis-induced mouse model and LPS-induced HK-2 cells.
Topics: Acute Kidney Injury; Animals; Apoptosis; Cyclooxygenase 2; Disease Models, Animal; I-kappa B Kinase; Inflammation; Isoxazoles; Lipopolysaccharides; Mice; NF-kappa B; Sepsis | 2022 |
Cytokine and radical inhibition in septic intestinal barrier failure.
Topics: Animals; Cyclic N-Oxides; Cyclooxygenase 2 Inhibitors; Drug Evaluation, Preclinical; Free Radical Scavengers; Interleukin-6; Intestinal Mucosa; Isoxazoles; Lipopolysaccharides; Male; Multiple Organ Failure; NADPH Oxidases; Neutrophils; Permeability; Pyruvic Acid; Rats, Sprague-Dawley; Sepsis; Spin Labels; Vasoactive Intestinal Peptide | 2015 |
Parecoxib does not suppress thromboxane synthesis in newborn piglets with group B streptococcal sepsis.
Topics: Animals; Animals, Newborn; Cyclooxygenase 2 Inhibitors; Dinoprostone; Epoprostenol; Gene Expression Regulation; Hemodynamics; Indomethacin; Inflammation; Isoxazoles; Lung; Platelet Count; Receptors, Prostaglandin E; Sepsis; Streptococcal Infections; Streptococcus agalactiae; Swine; Thromboxanes | 2009 |